The use of semaglutide (Ozempic) was tied to a small risk of nonarteritic anterior ischemic optic neuropathy (NAION) in ...

Adults with type 2 diabetes may have a higher risk for developing nonarteritic anterior ischemic optic neuropathy while using ...

American doctors, who tracked over 37 million people, said the injections put users at higher risk of nonarteritic ischemic ...

American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an ...

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

Catania first revealed that she was taking Ozempic in early 2023, sharing that she lost 20 lbs. by May of that year. The ...

Hims & Hers Health (NYSE: HIMS) tumbled 5.6% through 12:20 p.m. ET Thursday after Bank of America analysts gave mixed messages on the stock this morning. Raising its price target on the shares to $21, ...

Shortages and the sky-high cost of the new weight loss drugs has led to an explosion of compounded alternatives sold online, through telehealth sites and in compounding pharmacies. Unfortunately, most ...

Pursuing the world's first-ever orally-dosed liraglutide KELOWNA, BC / ACCESS Newswire / February 20, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global ...

Semaglutide is a GLP-1 agonist that works by reducing appetite, delaying gastric emptying, increasing insulin release, and lowering the amount of glucagon released. Semaglutide is a glucagon-like ...

Health professionals on the Rock suspect some people are acquiring weight loss injections, through non clinical means. The ...